Urolog. pro Praxi, 2005; 2: 58-61

A CONTROL OF MALE SEXUALITY ON CENTRAL LEVEL

MUDr. Michal Pohanka Ph.D1, prof. MUDr. Petr Kaňovský CSc2
1 Sexuologický ústav 1. LF UK a VFN, Praha
2 Neurologická klinika FN a LF UP Olomouc

All sexual functions are controlled by central nervous system. The control is facilitated by a number of neurotransmitters in the region of telencephalon, brain stem and spinal cord. A good quality of sexual act in a male subject requires a central integration of tactile, olfactory, auditory and mental stimuli, and adequate response to these stimuli. All above mentioned sensory functions and their central integration are mediated by neurotransmitters. Dopaminergic and cholinergic transmission play a dominant role in central control of male sexual functions. Their disturbance in neurologic disorders results also in a sexual dysfunction.

Keywords: Key words: sexuality, erection, dopaminergic transmission, cholinergic transmission.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pohanka M, Kaňovský P. A CONTROL OF MALE SEXUALITY ON CENTRAL LEVEL. Urol. praxi. 2005;6(2):58-61.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Allard J, Giuliano F. Central nervous system agents in the treatment of erectile dysfunction: how do they work? Curr Urol Rep 2001; 2: 488-494. Go to original source... Go to PubMed...
    2. Andersson KE. Neurotransmitters: central and peripheral mechanisms. Int J Impot Res 2000; 12 (soppl. 4): 26-33. Go to original source... Go to PubMed...
    3. Brown E, Brown GM, Kofman O, Quarrington B. Sexual function and affect in parkinsonian men treated with L-DOPA. Am J Psychiatr 1978; 135: 1552-1555. Go to original source... Go to PubMed...
    4. Brown RG, Jahanshahi M, Quinn N, Marsden CD. Sexual dysfunction in patients with Parkinson´s disease and their partners. J Neurol Neurosurg Psychiatr 1990; 53: 480-486. Go to original source... Go to PubMed...
    5. Cummings JL. Behavioral complications of drug treatment in Parkinson´s disease. J Am Ger Soc 1991; 39: 708-716. Go to original source... Go to PubMed...
    6. Derouesne C, Guigot J, Chermat V, Winchester N, Lacomblez L. Sexual behavioral changes in Alzheimer disease. Alzheimer Dis Assoc Dis 1996; 10: 86-92. Go to original source... Go to PubMed...
    7. Derouesne C, Piquard A, Thibault S, Baudouin-Madec V, Lacomblez L. Non-cognitive symptoms in Alzheimer´s disease. A study of 150 community -dwelling patients using a questionnaire completed by the caregiver. Rev Neurol 2001; 157: 162-177.
    8. Fine J, Lang AE. Dose-induced penile erections in response to ropinirole therapy for Parkinson´s disease. Mov Disord 1999, 14: 701-702. Go to original source... Go to PubMed...
    9. Jimenez-Jimenez FJ, Tallon-Barranco A. Fluctuating penile erections related with levodopa therapy. Neurology 1999; 52: 210-212. Go to original source... Go to PubMed...
    10. Kaňovský P, Bareš M, Pohanka M, Rektor I. Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson´s disease. J Neurol 2002; 249: 112-114. Go to original source... Go to PubMed...
    11. Kaňovský P, Okáčová L, Rektor I. Alzheimerova choroba. Čes Slov Neurol Neurochir 1996, 59: 63-67.
    12. Lambert D, Waters CH. Sexual dysfunction in Parkinson´s disease. Clin Neurosci 1998; 5: 73-77. Go to PubMed...
    13. Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev 1995; 19: 19-38. Go to original source... Go to PubMed...
    14. Montorsi F, Salonia A, Deho F, Cestari A, Guazzoni G, Rigatti P, Stief C. Pharmacological management of erectile dysfunction. B J Urol 2003, 91: 446-454. Go to original source... Go to PubMed...
    15. Moore O, Gurevich T, Korczyn AD, Anca M, Shabtai H, Giladi N. Quality of sexual life in Parkinson´s disease. Parkinsonism Relat Disord 2002; 8: 243-246. Go to original source... Go to PubMed...
    16. O´Sullivan JD, Hughes AJ. Apomorphine-induced penile erections in Parkinson´s disease. Mov Disord 1998; 13: 536-539. Go to original source... Go to PubMed...
    17. Posen J, Moore O, Tassa DS, Ginzburg K, Drory M, Giladi N. Young women with PD: a group work experience. Soc Work Helat Care 2000; 32: 77-91. Go to original source... Go to PubMed...
    18. Raffaele R, Vecchio I, Giamusso B, Morgia G, Brunetto MB, Rampello L. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson´s disease. Eur Urol 2002, 41; 382-386. Go to original source... Go to PubMed...
    19. Rosen RC, Ashton AK. Prosexual drugs: empirical status of the, ,new aphrodisiacs". Arch Sex Behav 1993; 22: 521-543. Go to original source... Go to PubMed...
    20. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002; 39: 283-303. Go to original source... Go to PubMed...
    21. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989; 12: 375-383. Go to original source... Go to PubMed...
    22. Von Keitz AT, Stroberg P, Bukofzer S, Mallard A, Hibberd M. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction. B J Urol 2002; 89: 409-415. Go to original source... Go to PubMed...
    23. Weinman E, Ruskin PE. Levodopa dependence and hypersexuality in older Parkinson´s disease patients. Am J Ger Psych 1995; 3: 81-83. Go to original source...
    24. Wermuth L, Stenager E. Sexual problems in young patients with Parkinson´s disease. Acta Neurol Scand 1995; 91: 453-455. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.